Abstract
Nicotinic acid is an effective therapy in most forms of dyslipidemia and has been shown to reduce cardiovascular disease and death, yet its clinical use is limited by a prostaglandin...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
